Tech Stocks Bouncing Back 0 10.01.2024 17:15 Forbes.com On Monday, we learned Novartis is in talks to buy Cytokinetics, the maker of a promising cardiovascular drug. Партнёры Smi24.net Все новости за 24 часа Музыкальные новости Агрегатор новостей 24СМИ
